Bcl-2 and p53 overexpression as associated risk factors in transitional cell carcinoma of the bladder.
- 1 July 1998
- journal article
- research article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 30 (4) , 455-461
- https://doi.org/10.1007/bf02550226
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Relationship of p53 and bcl-2 to Prognosis in Muscle-Invasive Transitional Cell Carcinoma of the BladderJournal of Urology, 1996
- Bladder cancerCurrent Opinion in Oncology, 1996
- Apoptosis in cancer therapy: Crossing the thresholdCell, 1994
- The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosisCell, 1993
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993
- Regulation of the specific DNA binding function of p53Cell, 1992
- Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 allelesCell, 1992
- The p53 tumour suppressor geneNature, 1991
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990
- Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cellsNature, 1988